Delivery Order SPE2DB20D2002-SPE2DB23FL39N
Award Date 5/12/23
Potential Completion Date 5/15/23
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,576.04 Firm Fixed Price Delivery Order contract is for the provision of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has a period of performance through December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,811.00 fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has a period of performance through September 16, 2024 and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.40, is a delivery order for 1,440 units of the HAVRIX vaccine, a hepatitis A vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,501.10 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE, a hepatitis A vaccine, to support military healthcare programs. The contract has a period of performance through March 21, 2023 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,899.75 firm fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,623.60 firm fixed-price delivery order is for the supply of 1,440 units of the Hepatitis A vaccine HAVRIX. The award, which has no set-aside designation, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $16,944.90 firm fixed-price delivery order is for the supply of 1,440 units of the hepatitis A vaccine HAVRIX 1,440 UNIT/ML SYRINGE. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,839.60 firm fixed-price delivery order is for the supply of HAVRIX 720 Unit/0.5 ML syringes. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, with ID SPE2DX15D7062|SPE2DX25FJBWC, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.90 firm fixed-price delivery order is for the supply of HAVRIX 720/0.5ML 10S, a hepatitis A vaccine, with an ultimate completion date of October 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,912.82 firm fixed-price delivery order is for HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The contract has a period of performance through March 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...